Improvements in glycemic control and reductions in eGFR decline with some GLP-1 RAs have also been reported in patients with moderate to severe CKD (eGFR of >15 mL/min/1.73 m2) [18,89]. This evidence concerns the gene GLP1R and chronic kidney disease.